rs121964923
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The ENST00000351513.7(DPYS):āc.1001A>Gā(p.Gln334Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000558 in 1,614,222 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (ā ā ). Synonymous variant affecting the same amino acid position (i.e. Q334Q) has been classified as Benign.
Frequency
Genomes: š 0.000039 ( 0 hom., cov: 31)
Exomes š: 0.000057 ( 0 hom. )
Consequence
DPYS
ENST00000351513.7 missense
ENST00000351513.7 missense
Scores
11
7
1
Clinical Significance
Conservation
PhyloP100: 8.02
Genes affected
DPYS (HGNC:3013): (dihydropyrimidinase) Dihydropyrimidinase catalyzes the conversion of 5,6-dihydrouracil to 3-ureidopropionate in pyrimidine metabolism. Dihydropyrimidinase is expressed at a high level in liver and kidney as a major 2.5-kb transcript and a minor 3.8-kb transcript. Defects in the DPYS gene are linked to dihydropyrimidinuria. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 10 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 8-104428071-T-C is Pathogenic according to our data. Variant chr8-104428071-T-C is described in ClinVar as [Pathogenic]. Clinvar id is 184.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-104428071-T-C is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DPYS | NM_001385.3 | c.1001A>G | p.Gln334Arg | missense_variant | 6/10 | ENST00000351513.7 | NP_001376.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DPYS | ENST00000351513.7 | c.1001A>G | p.Gln334Arg | missense_variant | 6/10 | 1 | NM_001385.3 | ENSP00000276651 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152220Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
6
AN:
152220
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000477 AC: 12AN: 251414Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135874
GnomAD3 exomes
AF:
AC:
12
AN:
251414
Hom.:
AF XY:
AC XY:
6
AN XY:
135874
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000575 AC: 84AN: 1461884Hom.: 0 Cov.: 32 AF XY: 0.0000605 AC XY: 44AN XY: 727244
GnomAD4 exome
AF:
AC:
84
AN:
1461884
Hom.:
Cov.:
32
AF XY:
AC XY:
44
AN XY:
727244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152338Hom.: 0 Cov.: 31 AF XY: 0.0000403 AC XY: 3AN XY: 74498
GnomAD4 genome
AF:
AC:
6
AN:
152338
Hom.:
Cov.:
31
AF XY:
AC XY:
3
AN XY:
74498
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
11
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Dihydropyrimidinase deficiency Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 01, 1998 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Juno Genomics, Hangzhou Juno Genomics, Inc | - | PM2_Supporting+PP3_Strong+PM3_Strong+PP4 - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 14, 2022 | This missense change has been observed in individual(s) with DPYS deficiency (PMID: 25915935). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs121964923, gnomAD 0.08%). This sequence change replaces glutamine, which is neutral and polar, with arginine, which is basic and polar, at codon 334 of the DPYS protein (p.Gln334Arg). ClinVar contains an entry for this variant (Variation ID: 184). For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects DPYS function (PMID: 9718352, 28642038, 29054612). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt DPYS protein function. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
M
MutationTaster
Benign
A
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D
REVEL
Pathogenic
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at